Staphefekt, developed by the Dutch biotechnology company Micreos, is the world's first bacteria-killing enzyme targeting the Staphylococcus aureus-bacteria. It is available in Gladskin creams and gels for people with skin problems.
Scientists create drug to replace antibiotics
Share this article
Find out more
Scientists Develop Alternative To Antibiotics
New study suggests S. aureus and skin dysbioses cause eczema